Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Doxorubicin Hydrochloride | HCID 443939 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | Doxorubicin | HCID 31703 | — |
Reaction Steps
After dissolving 0.25 g of hydrazone linker-bound mPEG-PLGA obtained in Example 3 and 10 mg of doxorubicin-HCl in 7.5 ml of dimethylformamide, conjugation reaction was performed for 24 hours at room temperature under nitrogen gas to obtain doxorubicin-conjugated micelle monomers. The micelle monomers were dispersed in 300 ml of triple distilled water to form doxorubicin-conjugated sustained release micelles, and free doxorubicin was removed by dialyzing the mixture 5 times against 3 L of triple distilled water each time. Doxorubicin-conjugated sustained release micelles were pelletized by ultracentrifugation, and freeze-dried after removing supernatant, and then, stored in the form of doxorubicin-conjugated micelle monomers. The efficiency of conjugation of doxorubicin was determined analogously as in Example 2(see: Table 3 below).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06623729B2 |
|---|
| Source dataset | uspto-grants-2003_09 |
|---|
| ORD ID | ord-0556b18caacc48569f6c73034aafdb9d |
|---|
| Source note | uspto-grants-2003_09 |
|---|